Comparison of Two Liraglutide Formulations in Healthy Volunteers

NCT01508897 · Completed

Last updated 2026-05-28

This clinical trial compares two different forms of the medication liraglutide in healthy volunteers to study how the body absorbs and processes the drug.

Status Completed The study has finished.

Phase Phase 1 Checks safety and dosing in a small group.

Type Interventional (clinical trial)

Design Randomized, single-blind treatment study

Participants 22 people

Who can join Ages 18–50 · all sexes

Timeline Started 2004-05 · est. completion 2004-06

Where 1 site · Germany

What this study is testing ClinicalTrials.gov NCT01508897 ↗

Description as written by the study sponsor.

This trial is conducted in Europe. The aim of this trial is to test for bioequivalence of two formulations of liraglutide.

Treatments tested

liraglutide Drug

Single dose administered as subcutaneous injection
liraglutide Drug

Single dose administered as subcutaneous injection

Main thing measured	Area under the Curve (AUC) (0-t)
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Healthy
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01508897 ↗